EU’s Least Vaccinated Country Wants to Donate Shots to Neighbors
(Bloomberg) -- Bulgaria, the European Union country that has vaccinated the smallest share of its population, is planning to provide as many as 150,000 doses to its Balkan neighbors amid a lack of demand at home.
Skepticism toward the vaccines, poor organization and lack of trust in the institutions has slowed the inoculation process in the EU's poorest member, where less than 20% of the population has received at least one shot. While supplies earlier this year were delayed, Bulgaria now has enough vaccines for the current vaccination rate and has even asked for some deliveries to be postponed, Health Minister Stoycho Katsarov told reporters in Sofia on Thursday.
The country has asked the European Commission for options to donate or sell a part of its supplies amid requests from North Macedonia, Kosovo, Albania and Bosnia and Herzegovina, who have suffered difficulties in supplies, Katsarov said. Most of the doses planned for donation will be AstraZeneca shots, which Bulgarians don't want to use after their use was halted by some EU countries temporarily due to fears of complications.
“Our will is to help,” Katsarov said. “Our needs are completely satisfied. At this moment, there's no reason to expect that we can face deficits until the end of the year.”
Bulgaria has ordered as many as 14 million doses this year from Pfizer, AstraZeneca, Moderna and J&J. Three out of five Bulgarians, however, are unlikely to roll up their sleeves for vaccines, the highest share in the EU, according to a Eurofound survey conducted in February and March.
“Unfortunately we've seen rumors, anti-vaxer mantras,” Katsarov said. “We can only provide conditions and access” to vaccines.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.